Intrauterine Misoprostol Versus Intravenous Oxytocin for the Prevention of Primary Postpartum Hemorrhage During Cesarean Section: A One-Year Randomized Controlled Trial. Eastern Med. Coll. J. 2026, 10 (2), 111-115. https://doi.org/10.3329/emcj.v10i2.85706.